Friday , August 7 2020
Home / Tag Archives: adalimumab

Tag Archives: adalimumab

Glenmark Pharmaceutical launches biosimilar of Adalimumab in India

Glenmark Pharmaceuticals has launched the biosimilar of Adalimumab under a licensing agreement with Cadila Healthcare, the Zydus group for the treatment of Plaque Psoriasis and Rheumatoid Arthritis. Developed by the researchers at the Zydus Research Centre, the biosimilar of Adalimumab was first launched by Zydus in 2014 and is manufactured ... Read More »